<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7328712\results\search\testTrace\results.xml">
  <result pre="antivirals including remdesivir and lopinavir-ritonavir might have roles in the" exact="treatment" post="of COVID-19, but results from trials thus far have"/>
  <result pre="the spring of 2003, an outbreak of severe acute respiratory" exact="infection" post="(SARI) spread globally.1,2,3 The World Health Organization (WHO) coined"/>
  <result pre="related to SARS and MERS.4 COVID-19 is a respiratory tract" exact="infection" post="that causes mild symptoms in the majority of cases,"/>
  <result pre="broad-spectrum antibiotics to treat secondary bacterial infections was the main" exact="treatment" post="regimen.9 Ribavirin, a broad-spectrum purine nucleoside analogue, was empirically"/>
  <result pre="As of 2019, there is still no effective vaccine or" exact="treatment" post="for this disease, although a number of antiviral medications"/>
  <result pre="that there is still no general consensus on the optimal" exact="treatment" post="strategy for MERS-CoV infection.15 The MIRACLE trial (MERS-CoV Infection"/>
  <result pre="2020, giving a crude case-fatality rate of approximately 7%.22 Supportive" exact="treatment" post="is the mainstay of management, as no antiviral therapy"/>
  <result pre="proven to be effective against SARS-CoV-2, and no standard pharmacological" exact="treatment" post="guidelines have been recommended by WHO.4 Potential treatment strategies"/>
  <result pre="standard pharmacological treatment guidelines have been recommended by WHO.4 Potential" exact="treatment" post="strategies for COVID-19 SARS-CoV, MERS, and SARS-CoV-2 are all"/>
  <result pre="treatments and is currently comparing four of the most promising" exact="treatment" post="options: remdesivir, lopinavirâ€&quot;ritonavir, lopinavirâ€&quot;ritonavir plus interferon Î²-1a, and hydroxychloroquine.39"/>
  <result pre="the literature, with focus on pharmacological therapies (Table 1). Supportive" exact="treatment" post="Empirical antimicrobials should be started within 1 hour after"/>
  <result pre="Empirical antimicrobials should be started within 1 hour after the" exact="detection" post="of sepsis based on clinical diagnosis and local epidemiology.4"/>
  <result pre="1 hour after the detection of sepsis based on clinical" exact="diagnosis" post="and local epidemiology.4 For critically ill COVID-19 patients, intensive"/>
  <result pre="and local epidemiology.4 For critically ill COVID-19 patients, intensive care" exact="treatment" post="can include oxygen therapy, noninvasive mechanical ventilation, invasive mechanical"/>
  <result pre="clinical trial demonstrated that patients receiving a 5-day and 10-day" exact="treatment" post="course of remdesivir achieved similar improvements in clinical status.49"/>
  <result pre="the efficacy of lopinavirâ€&quot;ritonavir compared with other drugs as a" exact="treatment" post="for COVID-19.39,56â€&quot;58 Nevertheless, the results so far indicate that"/>
  <result pre="for COVID-19.39,56â€&quot;58 Nevertheless, the results so far indicate that lopinavirâ€&quot;ritonavir" exact="treatment" post="has little benefit as a standalone therapy against SARS-CoV-2"/>
  <result pre="clinical trial involving 199 patients with laboratory-confirmed SARS-CoV-2 infection, lopinavirâ€&quot;ritonavir" exact="treatment" post="was not associated with any clinical improvements compared with"/>
  <result pre="with any clinical improvements compared with standard care.54 Furthermore, lopinavirâ€&quot;ritonavir" exact="treatment" post="caused gastrointestinal adverse events, and nearly 14% of the"/>
  <result pre="viral replication is relatively high.54 Other clinical trials have been" exact="testing" post="lopinavirâ€&quot;ritonavir combined with different drugs and different combinations such"/>
  <result pre="and interferon 1b.39,56 Early use of lopinavirâ€&quot;ritonavir as an additional" exact="treatment" post="to ritonavirâ€&quot;methylprednisolone for SARS-CoV was associated with a reduction"/>
  <result pre="the use of lopinavirâ€&quot;ritonavir combined with interferon Î²-1b as a" exact="treatment" post="for MERS since 2016, but the trial is ongoing"/>
  <result pre="was associated with dose-dependent haemolysis and liver toxicity.63,64 In the" exact="treatment" post="of SARS and MERS, ribavirin is used in combination"/>
  <result pre="and hydroxychloroquine Chloroquine and hydroxychloroquine are widely used for the" exact="treatment" post="of malaria and certain autoimmune diseases. These drugs have"/>
  <result pre="such as intravenous methylprednisolone are currently being tested as a" exact="treatment" post="for COVID-19.77 Methylprednisolone has already been used in COVID-19"/>
  <result pre="reported the use of corticosteroids in early stages of SARS" exact="infection" post="increased the viral load.79 Furthermore, studies on the use"/>
  <result pre="the use of corticosteroids as an adjuvant therapy against MERS-CoV" exact="infection" post="were unable to prove efficacy because all patients died.80"/>
  <result pre="as a postexposure prophylaxis for COVID-19 and as a potential" exact="treatment" post="after infection, as it was also used as a"/>
  <result pre="prophylaxis may not be justifiable, but could still be a" exact="treatment" post="option. An observational study during the SARS epidemic showed"/>
  <result pre="lower mortality rate in those receiving convalescent plasma as a" exact="treatment" post="for SARS.82 Studies on the clinical effects and outcomes"/>
  <result pre="monoclonal antibody against IL-6, has recently been suggested as a" exact="treatment" post="for COVID-19 patients at risk of cytokine storms.90 Tocilizumab"/>
  <result pre="Clinical trials on the efficacy of intravenous tocilizumab as a" exact="treatment" post="for COVID-19 are ongoing.93,94 However, serious adverse effects have"/>
  <result pre="a coadjuvant therapy in the early stage of the SARS" exact="infection" post="epidemic was reported to increase oxyhaemoglobin arterial saturation.95 A"/>
  <result pre="interferon, and methylprednisolone (given to only ICU patients) showed good" exact="treatment" post="effects and the mortality rate was less than 1%.101,102"/>
  <result pre="interferon-a-1b, lopinavir, ritonavir, and short-term (3â€&quot;5 days) corticosteroids had good" exact="treatment" post="results and only one patient died.103 In a case"/>
  <result pre="similar in nature and have defined clinical presentations. The lower" exact="prevalence" post="of coronavirus diseases in children might be accounted for"/>
  <result pre="overlooked and therefore go undiagnosed. Comparing the immunopathology of SARS-CoV-2" exact="infection" post="between children and adults could reveal the pathology of"/>
  <result pre="the pathology of the disease and might lead to possible" exact="treatment" post="strategies for â€˜recurrentâ€™ novel coronavirus infections. There is currently"/>
  <result pre="â€˜recurrentâ€™ novel coronavirus infections. There is currently no approved antiviral" exact="treatment" post="for patients suspected of or confirmed with COVID-19. Research"/>
  <result pre="more about the safety and efficacy of specific treatments, and" exact="treatment" post="recommendations are likely to change to reflect the latest"/>
  <result pre="such as personal hygiene, wearing masks in the general population," exact="social distancing," post="surveillance programs for testing suspected cases, early quarantine, vigilant"/>
  <result pre="masks in the general population, social distancing, surveillance programs for" exact="testing" post="suspected cases, early quarantine, vigilant contact tracing, and preventing"/>
  <result pre="distancing, surveillance programs for testing suspected cases, early quarantine, vigilant" exact="contact tracing," post="and preventing healthcare-related transmission are key factors to stopping"/>
  <result pre="to stopping the COVID-19 pandemic.108 Although a safe and effective" exact="treatment" post="has yet to be found, the sheer number of"/>
  <result pre="communities around the world, we are hopeful that an effective" exact="treatment" post="or vaccine for COVID-19 can be developed in the"/>
  <result pre="Pulmonol200944101048104910.1002/ppul.2108519774678 4collab: World Health OrganizationClinical management of severe acute respiratory" exact="infection" post="when COVID-19 is suspectedhttps://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected. Published 2020Accessed April 16, 2020"/>
  <result pre="2020 5ShenKYangYWangTet al.Diagnosis, treatment, and prevention of 2019 novel coronavirus" exact="infection" post="in children: expertsâ€™ consensus statementWorld J Pediatr202010.1007/s12519-020-00343-7 6collab: World"/>
  <result pre="epidemic in Hong KongJ Epidemiol Community Health200357965265410.1136/jech.57.9.65212933765 9ChengVCCChanJFWToKKWYuenKYClinical management and" exact="infection" post="control of SARS: lessons learnedAntiviral Res2013100240741910.1016/j.antiviral.2013.08.01623994190 10ChengVCCTangBSFWuAKLChuCMYuenKYMedical treatment of"/>
  <result pre="management and infection control of SARS: lessons learnedAntiviral Res2013100240741910.1016/j.antiviral.2013.08.01623994190 10ChengVCCTangBSFWuAKLChuCMYuenKYMedical" exact="treatment" post="of viral pneumonia including SARS in immunocompetent adultJ Infect200449426227310.1016/j.jinf.2004.07.01015474623"/>
  <result pre="in immunocompetent adultJ Infect200449426227310.1016/j.jinf.2004.07.01015474623 11ChuCMChengVCCHungIFNet al.Role of lopinavir/ritonavir in the" exact="treatment" post="of SARS: initial virological and clinical findingsThorax200459325225610.1136/thorax.2003.01265814985565 12LauACYamLYSoLKManagement of"/>
  <result pre="respiratory syndromeLancet20152569997995100710.1016/S0140-6736(15)60454-8 15MomattinHAl-AliAYAl-TawfiqJAA systematic review of therapeutic agents for the" exact="treatment" post="of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV)Travel Med"/>
  <result pre="of a fatal case of middle east respiratory syndrome coronavirus" exact="infection" post="in the United Arab Emirates, April 2014Am J Pathol2016186365265810.1016/j.ajpath.2015.10.02426857507"/>
  <result pre="April 16, 2020 40JinYHCaiLChengZSet al.A rapid advice guideline for the" exact="diagnosis" post="and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia"/>
  <result pre="2020 40JinYHCaiLChengZSet al.A rapid advice guideline for the diagnosis and" exact="treatment" post="of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)Mil"/>
  <result pre="April 16, 2020 52collab: US National Library of MedicineAdaptive COVID-19" exact="treatment" post="trialhttps://clinicaltrials.gov/ct2/show/NCT04280705. Published 2020Accessed February 29, 2020 53collab: EU Clinical"/>
  <result pre="on the efficacy and safety of Xiyanping injection in the" exact="treatment" post="of new coronavirus infection pneumonia (General and Severe)https://clinicaltrials.gov/ct2/show/NCT04295551Accessed April"/>
  <result pre="safety of Xiyanping injection in the treatment of new coronavirus" exact="infection" post="pneumonia (General and Severe)https://clinicaltrials.gov/ct2/show/NCT04295551Accessed April 22, 2020 58collab: US"/>
  <result pre="trial): study protocol for a randomized controlled trialTrials20181918110.1186/s13063-017-2427-029382391 61KhaliliJSZhuHMakNSAYanYZhuYNovel coronavirus" exact="treatment" post="with ribavirin: groundwork for an evaluation concerning COVID-19J Med"/>
  <result pre="an evaluation concerning COVID-19J Med Virol202010.1002/jmv.25798 62StockmanLJBellamyRGarnerPSARS: systematic review of" exact="treatment" post="effectsPLoS Med200639e34310.1371/journal.pmed.003034316968120 63BoothCMClinical features and short-term outcomes of 144"/>
  <result pre="Health Commission &amp;amp; State Administration of Traditional Chinese MedicineDiagnosis and" exact="treatment" post="protocol for novel coronavirus pneumoniahttp://busan.china-consulate.org/chn/zt/4/P020200310548447287942.pdf. Published 2020Accessed April 17,"/>
  <result pre="al.Triple combination of interferon beta-1b, lopinavirâ€&quot;ritonavir, and ribavirin in the" exact="treatment" post="of patients admitted to hospital with COVID-19: an open-label,"/>
  <result pre="review on the efficacy and safety of chloroquine for the" exact="treatment" post="of COVID-19J Crit Care20203710.1016/j.jcrc.2020.03.005 70GaoJTianZYangXBreakthrough: chloroquine phosphate has shown"/>
  <result pre="Crit Care20203710.1016/j.jcrc.2020.03.005 70GaoJTianZYangXBreakthrough: chloroquine phosphate has shown apparent efficacy in" exact="treatment" post="of COVID-19 associated pneumonia in clinical studiesBiosci Trends2020141727310.5582/bst.2020.0104732074550 71GautretPLagierJ-CParolaPet"/>
  <result pre="in clinical studiesBiosci Trends2020141727310.5582/bst.2020.0104732074550 71GautretPLagierJ-CParolaPet al.Hydroxychloroquine and azithromycin as a" exact="treatment" post="of COVID-19: results of an open-label non-randomized clinical trialInt"/>
  <result pre="clmedRxiv202010.1101/2020.04.07.20056424 73MehraMRDesaiSSRuschitzkaFPatelANHydroxychloroquine or chloroquine with or without a macrolide for" exact="treatment" post="of COVID-19: a multinational registry analysisLancet202010.1016/S0140-6736(20)31180-6 74MehraMRRuschitzkaFPatelANRetraction-Hydroxychloroquine or chloroquine"/>
  <result pre="analysisLancet202010.1016/S0140-6736(20)31180-6 74MehraMRRuschitzkaFPatelANRetraction-Hydroxychloroquine or chloroquine with or without a macrolide for" exact="treatment" post="of COVID-19: a multinational registry analysisLancet202010.1016/S0140-6736(20)31324-6 75PrincipiNEspositoSCorrespondence chloroquine or"/>
  <result pre="J Clin Exp Med20169588658873http://www.ijcem.com/files/ijcem0020929.pdf 79LeeNAllen ChanKCHuiDSet al.Effects of early corticosteroid" exact="treatment" post="on plasma SARS-associated coronavirus RNA concentrations in adult patientsJ"/>
  <result pre="plasmaJAMA - J Am Med Assoc202010.1001/jama.2020.4783 87StockmanLJBellamyRGarnerPSARS: systematic review of" exact="treatment" post="effectsPLoS Med2006391525153110.1371/journal.pmed.0030343 88collab: Takeda Pharmaceutical Company LimitedGlobal plasma leaders"/>
  <result pre="potential COVID-19 hyperimmune therapyhttps://www.thepharmaletter.com/article/global-plasma-leaders-collaborate-on-potential-covid-19-hyperimmune-therapy. Published 2020Accessed April 16, 2020 90LuoPLiuYQiuLLiuXLiuDLiJTocilizumab" exact="treatment" post="in COVID-19: a single center experienceJ Med Virol2020March1510.1002/jmv.2580131502247 91DiaoBWangCTanYet"/>
  <result pre="cells in patients with coronavirus disease 2019 (COVID-19)medRxiv2202010.1101/2020.02.18.20024364 92XuXHanMLiTet al.Effective" exact="treatment" post="of severe COVID-19 patients with tocilizumabProc Natl Acad Sci"/>
  <result pre="94collab: Chinese Clinical Trial RegistryFavipiravir combined with tocilizumab in the" exact="treatment" post="of novel coronavirus pneumonia (COVID-19 ) - a multicenter,"/>
  <result pre="of SARS coronavirus to selected antiviral compoundsJ Clin Virol2004311697510.1016/j.jcv.2004.03.00315288617 99WangSQDuQSZhaoKLiAXWeiDQChouKCVirtual" exact="screening" post="for finding natural inhibitor against cathepsin-L for SARS therapyAmino"/>
  <result pre="cathepsin-L for SARS therapyAmino Acids200733112913510.1007/s00726-006-0403-116998715 100YangYIslamMSWangJLiYChenXTraditional Chinese medicine in the" exact="treatment" post="of patients infected with 2019-new coronavirus (SARS-CoV-2): a review"/>
  <result pre="narrative literature reviewArch Acad Emerg Med202081e29http://www.ncbi.nlm.nih.gov/pubmed/3223221432232214 102QinXQiuSYuanYet al.Clinical characteristics and" exact="treatment" post="of patients infected with COVID-19 in Shishou, ChinaSSRN Electron"/>
  <result pre="National Library of MedicineThe impact of camostat mesilate on COVID-19" exact="infection" post="(CamoCO-19)https://clinicaltrials.gov/ct2/show/NCT04321096?term=camostat+mesilate&amp;amp;cond=COVID&amp;amp;draw=2&amp;amp;rank=4. Published 2020Accessed April 22, 2020 115collab: US National"/>
  <result pre="MedicineVarious combination of protease inhibitors, oseltamivir, favipiravir, and hydroxychloroquine for" exact="treatment" post="of COVID-19: a randomized control trial (THDMS-COVID-19) 116FletcherCVOverview of"/>
  <result pre="of side effects of nucleoside and nucleotide drugs used for" exact="treatment" post="of chronic hepatitis BCurr Hepat Rep201092759010.1007/s11901-010-0039-120461127 118Lexicomp OnlineFavipiravir (United"/>
  <result pre="2020Accessed April 18, 2020 121collab: University of MichiganInpatient guidance for" exact="treatment" post="of COVID-19 in adults and childrenhttp://www.med.umich.edu/asp/pdf/adult_guidelines/COVID-19-treatment.pdf. Published 2020Accessed April"/>
  <result pre="Medicine.66 Stage of COVID-19 disease and symptoms Recommended formulation Before" exact="diagnosis" post="Fatigue and gastrointestinal discomfort Huoxiang Zhengqi capsules Fatigue and"/>
  <result pre="g, delivered with Suhexiang pill or Angong Niuhuang pill. Viral" exact="infection" post="or combined mild bacterial infection Xiyanping injection 100 mg"/>
  <result pre="or Angong Niuhuang pill. Viral infection or combined mild bacterial" exact="infection" post="Xiyanping injection 100 mg bid High fever with disturbance"/>
  <result pre="g, salviae miltiorrhiza 15 g, raw liquorice 6 g. *Suggested" exact="treatment" post="regimen and dosages are adapted from the seventh version"/>
 </snippets>
</snippetsTree>
